Russian
French
 
 
-ISO 9001:2000
   
 

Duophase

Dosing schedule of drugs with short half life is usually three or even four times a day. This is obviously very inconvenient. An extended release drug delivery with a mono-phasic drug release from the matrix usually doesn't provide a pharmacokinetic profile which provides meaningful therapeutic action. To provide therapeutically meaningful extended delivery of such drugs, Troikaa has developed the Duophase Technology. Through this technology, the drug dose is split judiciously into two components, where one part delivers the drug immediately and the other releases the drug in a sustained release pattern. Thus, the drug delivery is biphasic and ensures the requisite pharmacokinetic profile. Drugs developed using this technology are extended release Paracetamol tablets of 650mg. and 1000mg. (Xykaa Extend) and extended release Ibuprofen tablets of 600 mg.

Products manufactured using Duophase Technology are presented in stylised tablets which graphically represent the biphasic drug delivery.

 

back to Innovative Technologies

 
- - -
Overview
AquaTech
Decompaction
DrySolve
Duophase
IFC
Intraoral Drug Delivery
Lipisol
LipoTech
LiquiCaps
Matrix
Maxisorb
Microsolve
Mucogrip
Organogel
Parenteral Nano Emulsion
Pre Filled Syringes (PFS)
Quick Penetrating Solution (QPS)
SoluTech
 

Products manufactured using Duophase Technology:

Extended release Paracetamol tablets of 650mg. and 1000mg.

Extended release Ibuprofen tablets of 600 mg.

 
Xykaa Extend
Xykaa Extend
   
 
::: Research Publications
 
   

Home | Company | Products | Technologies | International Business | Media Coverage | Human Resources | Research Publications | Partnering

Copyright ę 2009 Troikaa Pharmaceuticals Ltd. - Disclaimer